NUS

AIMCO APPOINTS LEADER FOR ASIA-PAC

Retrieved on: 
Tuesday, May 30, 2023

In addition to his global responsibilities, he will also set the strategic direction of our team in Singapore.

Key Points: 
  • In addition to his global responsibilities, he will also set the strategic direction of our team in Singapore.
  • AIMCo is among Canada's largest and most diversified institutional investment managers with $158 billion of assets under management.
  • AIMCo invests globally on behalf of 17 pension, endowment and government fund clients in the Province of Alberta.
  • AIMCo manages more than 30 pools of capital on behalf of these clients.

AIMCO APPOINTS LEADER FOR ASIA-PAC

Retrieved on: 
Tuesday, May 30, 2023

EDMONTON, AB, May 30, 2023 /PRNewswire/ -- Alberta Investment Management Corporation (AIMCo) is pleased to announce the appointment of Kevin Bong as Senior Managing Director, Chief Investment Strategist and Head of Singapore. Mr. Bong, who brings with him 20 years of global portfolio construction and capital allocation experience, will assume his new role August 14.

Key Points: 
  • AIMCo is among Canada's largest and most diversified institutional investment managers with $158 billion of assets under management.
  • AIMCo invests globally on behalf of 17 pension, endowment and government fund clients in the Province of Alberta.
  • AIMCo manages more than 30 pools of capital on behalf of these clients.
  • For more information about AIMCo please follow us on LinkedIn or Twitter .

Next&Bio and CSI Singapore Sign MOU for Organoid Collaboration

Retrieved on: 
Tuesday, May 16, 2023

Under the MOU, CSI Singapore and Next&Bio will discuss opportunities to establish a joint cancer organoid laboratory, and to pursue joint projects.

Key Points: 
  • Under the MOU, CSI Singapore and Next&Bio will discuss opportunities to establish a joint cancer organoid laboratory, and to pursue joint projects.
  • Under discussion will be the potential for Next&Bio to utilize their organoid culture technology to generate an organoid bank through collaborations with experts at CSI Singapore, which can be used for cancer patient-derived organoid-based research projects and developing patient-specific drug evaluation platforms using organoids.
  • The proposed collaboration with CSI Singapore will take advantage of the diverse ethnic backgrounds represented in Singapore to create an Asian hub for cancer organoid-based precision medicine.
  • We look forward to building an organoid bank at CSI Singapore with multiple cancer tissues to further facilitate research into individualized treatment.”

Nu Skin Enterprises Announces Resignation of CFO; Reiterates First Quarter and 2023 Outlook

Retrieved on: 
Thursday, March 30, 2023

PROVO, Utah, March 30, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the resignation of its chief financial officer, Mark Lawrence, effective March 31, 2023. After six years at the company, Lawrence has elected to pursue an outside opportunity but will remain as a senior advisor through April 2023 to support a smooth transition. Additionally, the company is reiterating first quarter and annual 2023 guidance provided on Feb. 15, 2023.

Key Points: 
  • PROVO, Utah, March 30, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the resignation of its chief financial officer, Mark Lawrence, effective March 31, 2023.
  • Additionally, the company is reiterating first quarter and annual 2023 guidance provided on Feb. 15, 2023.
  • "On behalf of our board, management and the entire Nu Skin team, we thank Mark for his leadership and significant contributions over the past six years," said Ryan Napierski, president and CEO.
  • A replay of the webcast will be available at the same location through Wednesday, May 17, 2023.

The DLT Science Foundation Makes its Public Launch to Revolutionize Industries and Society with Distributed Ledger Technology

Retrieved on: 
Monday, March 20, 2023

LONDON, March 20, 2023 /PRNewswire/ -- The DLT Science Foundation (DSF), a global, non-profit organisation, launched today with the goals of expanding knowledge and adoption of, and removing barriers to, fundamental breakthroughs in the field of distributed ledger technology (DLT).

Key Points: 
  • With the support of Hedera, the DLT Science Foundation will empower cutting-edge education, research and innovation in DLT through its open network of world-class universities.
  • The DSF has been initially supported by Hedera , the open-source, leaderless proof-of-stake network, which will also lend valuable DLT expertise to the DSF University Network.
  • The DLT Science Foundation aims to drive innovation, foster new collaborative models between academia, industry, and government, and promote the responsible adoption of DLT in business and society.
  • To join the DLT Science Foundation's University Network today and accelerate the development of education, research and innovation in academia and beyond, visit https://www.dltscience.org/ .

The DLT Science Foundation Makes its Public Launch to Revolutionize Industries and Society with Distributed Ledger Technology

Retrieved on: 
Monday, March 20, 2023

- With the support of Hedera, the DLT Science Foundation will empower cutting-edge education, research and innovation in DLT through its open network of world-class universities.

Key Points: 
  • - With the support of Hedera, the DLT Science Foundation will empower cutting-edge education, research and innovation in DLT through its open network of world-class universities.
  • Paolo Tasca, Chairman and co-founder of the DSF said, "After two years of hard work and dedication, I am thrilled to announce the launch of the DLT Science Foundation.
  • The DLT Science Foundation aims to drive innovation, foster new collaborative models between academia, industry, and government, and promote the responsible adoption of DLT in business and society.
  • To join the DLT Science Foundation's University Network today and accelerate the development of education, research and innovation in academia and beyond, visit www.dltscience.org/.

NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics

Retrieved on: 
Monday, March 6, 2023

UPPSALA, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medicine Protein Biomarker Discovery Core Facility, which will provide the Olink® Explore 3072, Olink® Explore 1536, Olink® Target 96 and Target 48, and the recently launched Olink® Flex platforms.

Key Points: 
  • UPPSALA, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medicine Protein Biomarker Discovery Core Facility, which will provide the Olink® Explore 3072, Olink® Explore 1536, Olink® Target 96 and Target 48, and the recently launched Olink® Flex platforms.
  • The launch of this core facility at NUS Medicine strengthens Olink’s presence in the South Asia Pacific region, offering its highly innovative proteomics technologies to a wider audience.
  • Based at NUS Medicine, the core facility will support researchers and scientists from NUS and the industry, both locally and globally in their understanding of disease, as well as the effects and outcomes of treatment.
  • We welcome Olink as our primary proteomics partner in Singapore - their cutting-edge technology will provide detailed and comprehensive proteomics data covering all major biological pathways and processes,” said Prof Chong Yap Seng, Lien Ying Chow Professor in Medicine, Dean, NUS Medicine.

NUS and Emeritus Launch Chief Technology Officer Programme to Prepare CTOs for Facing Technology Challenges

Retrieved on: 
Monday, March 6, 2023

NUS School of Computing’s Chief Technology Officer (CTO) Programme is a cutting-edge 9-month programme that is designed for commercially driven technology/digital leaders with 10+ years of work experience and 5 years of management and technology experience, who want to emerge as a transformative technology leader by becoming a trusted advisor to the CEO.

Key Points: 
  • NUS School of Computing’s Chief Technology Officer (CTO) Programme is a cutting-edge 9-month programme that is designed for commercially driven technology/digital leaders with 10+ years of work experience and 5 years of management and technology experience, who want to emerge as a transformative technology leader by becoming a trusted advisor to the CEO.
  • The Chief Technology Officer (CTO) Programme is intended for professionals who want to advance their skills in digital innovation, strategy, organisation, cutting-edge technologies, and leadership development.
  • This is the first Chief Technology Officer (CTO) programme in Singapore offered by a premier global University.
  • Speaking about the programme, Mohan Kannegal, CEO, India and APAC, Emeritus, said, “With the growing demand for skilled CTOs across all industries, we have curated the NUS School of Computing’s Chief Technology Officer (CTO) Programme.

Richard Runyon is recognized by Continental Who's Who

Retrieved on: 
Monday, February 13, 2023

SEATTLE, Wash., Feb. 13, 2023 /PRNewswire/ -- Richard Runyon is being recognized by Continental Who's Who as a Distinguished Business Professional for his work as Senior Investigator and Analyst.

Key Points: 
  • SEATTLE, Wash., Feb. 13, 2023 /PRNewswire/ -- Richard Runyon is being recognized by Continental Who's Who as a Distinguished Business Professional for his work as Senior Investigator and Analyst.
  • Mr. Runyon earned a criminal justice degree at California State University, which he notes is where he discovered his love for science.
  • According to Mr. Runyon, the AAAS seeks to "advance science, engineering, and innovation throughout the world for the benefit of all people."
  • Mr. Runyon credits his success to perseverance, flexibility, and passion for travel to provide community education on his specialty topics.

KoverNow Appoints one of Singapore’s Most Prominent Marketing and Data Science Experts as Non-Executive Director

Retrieved on: 
Tuesday, January 31, 2023

Professor Chong, who is a behavioral scientist and data scientist by training, currently carries out research focusing on the challenges of nudging people to adopt useful technology.

Key Points: 
  • Professor Chong, who is a behavioral scientist and data scientist by training, currently carries out research focusing on the challenges of nudging people to adopt useful technology.
  • He joins KoverNow as a non-executive director.
  • Professor Chong’s expertise is in using behavioral and economic principles and data analytics and AI tools.
  • Stephan Kaiser, CEO at KoverNow, said: “Professor Chong has a rich history of advising start-ups in the application of big data and artificial intelligence to their marketing strategies.